BioSpace News Archive

Assembly Biosciences, Inc. announced that John McHutchison, AO, MD, Chief Executive Officer and President, will present during the Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020 at 1:30 pm ET.

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that management will present at the June 2020 Virtual Investor Summit on June 9-12, 2020. Marrone Bio Innovations management will host virtual one-on-one investor meetings throughout the event and is scheduled to present as follows: Virtual Investor Summit Date: Tuesday, June 9,

Sharps Compliance Corp. announced that David P. Tusa, Chief Executive Officer will be presenting at the Stifel 2020 Virtual Cross Sector Conference on June 9, 2020 at 9:20 a.m. Eastern time.

Pegzilarginase Showed Durable Clinical Response at 56 Week Analysis All Patients Demonstrated a Marked and Sustained Reduction in Plasma Arginine Favorable Safety Profile, Consistent with Previously Reported Results AUSTIN, Texas, May 26, 2020 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare and other high-burden diseases, today announced a

– New project seeks to expand on positive preliminary results from ongoing research program with McMaster University to develop innovative drug delivery systems using disruptive PGX Technology – Ceapro at the forefront of pioneering approaches with natural products through utilizing validated enabling technology

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing treatments for rare and specialty diseases with significant unmet needs, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Intravenous (IV) Choline Chloride for the treatment of intestinal failure-associated liver disease (IFALD). IV Choline Chloride is the Company’s Phase 3-ready investigational phospholipid substrate re

A research team from Colorado State University, Virginia Tech and GenoFAB – a cloud computing company focused on high-throughput laboratory automation – have completed one of the largest quantitative experiments looking at the genetic control of cell growth and division in yeast.

Aerotek , a leading provider of recruiting and staffing services, today announced it will host a webinar in partnership with the Virtual Association of Clinical Research Professionals (ACRP)

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) announced today that following positive feedback from the U.S. Food and Drug Administration the company plans to combine its CLARITY-2 and CLARITY-3 Phase 3 studies evaluating pimavanserin for the adjunctive treatment of major depressive disorder (MDD) into one study with a pre-specified statistical analysis plan. As a result, no new patients

Hygea Precision Medicine (Hygea), a company focused on developing a precision medicine software system for healthcare providers and patients to effectively manage genomic testing, and Admera Health, a premier precision medicine company and genetics laboratory, are pleased to announce a formal, agreed partnership. Eyal Odiz, CEO and Co-Founder of Hygea commented, “This important and strategic partnership will allow Hyg